Fibrinolysis is a crucial physiological process that helps to maintain a hemostatic balance by
counteracting excessive thrombosis. The components of the fibrinolytic system are well …

Purpose Venous thromboembolism (VTE) is a well-recognized complication of cancer.
Laboratory parameters might be useful to assess the VTE risk in patients with cancer. The …

Background: Growing evidence showed that high pretreatment plasma fibrinogen could be
used as a potential prognostic marker in colorectal cancer (CRC). However, the conclusions …

Abnormal hemostasis in cancer patients has prev iously been studied. The primary objective
of the present study was to evaluate the association between preoperative hemostasis …

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of cancer and has a poor
prognosis. Patients with PDAC are at high risk of developing thromboembolic events, which …

Thrombotic complications have been documented in patients with cancer, and associated
with tumor progression. Cancer patients have an increased level of circulating …

By comparative proteome analysis we searched for characteristic alterations of human
plasma accompanying neoplastic disease. We identified protein alterations in plasma of …

Cancer-related fibrin deposition and fibrinolysis were investigated by two-dimensional gel
electrophoresis of human solid tumor and effusion specimen in addition to plasma samples …

Purpose Activation of coagulation and fibrinolysis is frequently found among cancer patients.
Such tumors are considered to be associated with a higher risk of invasion, metastases, and …

The expression of melanotransferrin (MTf), a membrane-bound glycoprotein highly
expressed in melanomas, is correlated with tumor vascularization and progression …